These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12475179)

  • 1. Physicochemical profiling in drug research: a brief survey of the state-of-the-art of experimental techniques.
    Avdeef A; Testa B
    Cell Mol Life Sci; 2002 Oct; 59(10):1681-9. PubMed ID: 12475179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical tools for the physicochemical profiling of drug candidates to predict absorption/distribution.
    Henchoz Y; Bard B; Guillarme D; Carrupt PA; Veuthey JL; Martel S
    Anal Bioanal Chem; 2009 Jun; 394(3):707-29. PubMed ID: 19184676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical profiling (solubility, permeability and charge state).
    Avdeef A
    Curr Top Med Chem; 2001 Sep; 1(4):277-351. PubMed ID: 11899112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High throughput solubility measurement in drug discovery and development.
    Alsenz J; Kansy M
    Adv Drug Deliv Rev; 2007 Jul; 59(7):546-67. PubMed ID: 17604872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro trans-monolayer permeability calculations: often forgotten assumptions.
    Youdim KA; Avdeef A; Abbott NJ
    Drug Discov Today; 2003 Nov; 8(21):997-1003. PubMed ID: 14643163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery.
    Wan H; Holmén AG
    Comb Chem High Throughput Screen; 2009 Mar; 12(3):315-29. PubMed ID: 19275537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonclassical Zwitterions as a Design Principle to Reduce Lipophilicity without Impacting Permeability.
    Möbitz H; Dittrich B; Rodde S; Strang R
    J Med Chem; 2024 Jun; 67(11):9485-9494. PubMed ID: 38747896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
    Deák K
    Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space.
    Ermondi G; Vallaro M; Goetz G; Shalaeva M; Caron G
    Eur J Pharm Sci; 2020 Apr; 146():105274. PubMed ID: 32088315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of mass spectrometry for pharmaceutical profiling applications.
    Kerns EH; Di L
    Curr Drug Metab; 2006 Jun; 7(5):457-66. PubMed ID: 16787155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical cocrystals: an overview.
    Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
    Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical predictions of drug absorption in drug discovery and development.
    Stenberg P; Bergström CA; Luthman K; Artursson P
    Clin Pharmacokinet; 2002; 41(11):877-99. PubMed ID: 12190333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipophilicity and biomimetic properties to support drug discovery.
    Tsopelas F; Giaginis C; Tsantili-Kakoulidou A
    Expert Opin Drug Discov; 2017 Sep; 12(9):885-896. PubMed ID: 28644732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM; Griffin BT
    Adv Drug Deliv Rev; 2008 Mar; 60(6):617-24. PubMed ID: 18155800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of physicochemical and molecular properties in drug design: navigation in the "drug-like" chemical space.
    Vallianatou T; Giaginis C; Tsantili-Kakoulidou A
    Adv Exp Med Biol; 2015; 822():187-94. PubMed ID: 25416989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeability diagnosis model in drug discovery: a diagnostic tool to identify the most influencing properties for gastrointestinal permeability.
    Wang J; Skolnik S
    Curr Top Med Chem; 2013; 13(11):1308-16. PubMed ID: 23675937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of lipophilicity in drug discovery and design.
    Arnott JA; Planey SL
    Expert Opin Drug Discov; 2012 Oct; 7(10):863-75. PubMed ID: 22992175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive approaches to increase absorption of compounds during lead optimisation.
    Valko K; Butler J; Eddershaw P
    Expert Opin Drug Discov; 2013 Oct; 8(10):1225-38. PubMed ID: 23865945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches for high-throughput pharmacokinetic screening of low-molecular-weight drug candidates.
    Fontana S
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):139-42. PubMed ID: 24329157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.